Literature DB >> 29329092

Effect of aspirin on the pharmacokinetics and absorption of panax notoginseng saponins.

Zhihao Tian1, Huanhuan Pang1, Qiang Zhang1, Shouying Du2, Yang Lu3, Lin Zhang1, Jie Bai1, Pengyue Li1, Danqi Li1, Mengdi Zhao1, Xiaonan Chen1.   

Abstract

BACKGROUND: Panax notoginseng saponins, a traditional Chinese medicine extraction, and aspirin are both widely used to treat cerebral infarction in China. Good results in clinical practice have been achieved, when Panax notoginseng saponins was taken together with aspirin.
METHODS: To investigate the interaction of the two drugs in vivo, the concentration of notoginsenoside R1, ginsenoside Rg1, Rb1, Re and Rd. in blood were simultaneously measured by UPLC/MS/MS. Sample preparation was carried out by the protein precipitation technique with an internal standard saikosaponin A standard. The separation of six components was achieved by using an ACQUITY UPLC ®BEH C18 column (1.7μm 2.1×100mm) by gradient elution using water (containing 0.2% formic acid) and acetonitrile (containing 0.2% formic acid) as the mobile phase at a flow rate of 0.2mL/min. The pharmacokinetic parameters were determined using non-compartmental analysis. The transport of notoginsenoside R1, ginsenoside Rg1, Rb1, Re and Rd. in MDCK -MDR1 cell monolayer was also used to verify the conclusion of pharmacokinetic drug-drug interaction and study the mechanism of drug interaction.
RESULTS: The concentrations of the five components increased in a certain extent when the two drugs administered together in rats. The values of apparent permeability coefficients were significantly increased when the two drugs were used together. Aspirin and salicylic acid could destroy the tight junction protein and open the intercellular space to increase the absorption of Panax notoginseng saponins.
CONCLUSION: Pharmacokinetic drug-drug interaction in vivo existed between Panax notoginseng saponins and aspirin. The drug-drug interaction mainly occurred in the process of absorption.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aspirin; Drug-drug interaction; Panax notoginseng saponins; Pharmacokinetic; Transport

Mesh:

Substances:

Year:  2018        PMID: 29329092     DOI: 10.1016/j.jchromb.2017.12.033

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Potential Pharmacokinetic Drug⁻Drug Interaction Between Harmine, a Cholinesterase Inhibitor, and Memantine, a Non-Competitive N-Methyl-d-Aspartate Receptor Antagonist.

Authors:  Yunpeng Zhang; Shuping Li; Youxu Wang; Gang Deng; Ning Cao; Chao Wu; Wenzheng Ding; Yuwen Wang; Xuemei Cheng; Changhong Wang
Journal:  Molecules       Date:  2019-04-11       Impact factor: 4.411

Review 2.  Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases.

Authors:  Hai Liu; Jianqiong Yang; Wanqing Yang; Shaonan Hu; Yali Wu; Bo Zhao; Haiyan Hu; Shouying Du
Journal:  Drug Des Devel Ther       Date:  2020-02-07       Impact factor: 4.162

3.  The Relationship between Compound Danshen Dripping Pills with Isosorbide Mononitrate in the Treatment of Elderly Patients with Unstable Angina Pectoris.

Authors:  Yulin Liang; Junbo Zou; Xiaofei Zhang; Yu Wang; Jia Tai; Dongyan Guo; Chunli Cui; Jing Wang; Jiangxue Cheng; Yajun Shi
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-18       Impact factor: 2.629

Review 4.  Saponins as Modulators of the Blood Coagulation System and Perspectives Regarding Their Use in the Prevention of Venous Thromboembolic Incidents.

Authors:  Beata Olas; Karina Urbańska; Magdalena Bryś
Journal:  Molecules       Date:  2020-11-06       Impact factor: 4.411

Review 5.  Herb-Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements.

Authors:  Annemarie Lippert; Bertold Renner
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241

6.  Combination of Xuesaitong and Aspirin Based on the Antiplatelet Effect and Gastrointestinal Injury: Study Protocol for a Randomized Controlled Noninferiority Trial.

Authors:  Bao-Chen Zhu; Chun-Miao Xue; Rui Lang; Wei-Liang Weng; Xu-Jie Wang; Zhen-Zhen Lei; Sha-Sha Zhang; Wen-Hua Yang; Wan-Tong Zhang; Guo-Dong Hua
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.